Open Access
CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2018; 09(03): 114-117
DOI: 10.4103/jde.JDE_41_17
Original Article
Journal of Digestive Endoscopy

Soft Coagulation Using Hemostatic Forceps for Prevention of Postendoscopic Papillectomy Hemorrhage

Nobuhiko Fukuba
Department of Internal Medicine II, Shimane University School of Medicine, Shimane, Japan
,
Hiroki Sonoyama
Department of Internal Medicine II, Shimane University School of Medicine, Shimane, Japan
,
Ichiro Moriyama
1   Division of Cancer Center, Shimane University Hospital, Shimane, Japan
,
Shunji Ishihara
Department of Internal Medicine II, Shimane University School of Medicine, Shimane, Japan
,
Yoshikazu Kinoshita
Department of Internal Medicine II, Shimane University School of Medicine, Shimane, Japan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
24. September 2019 (online)

Preview

Aim: Few reports of the prophylactic use of soft coagulation with hemostatic forceps for postendoscopic papillectomy hemorrhage (PEPH) have been presented. The aim of this study was to clarify the utility of that procedure for prophylaxis. Materials and Methods: From April 2009 to March 2012, PEPH was treated in four patients after the development of the condition with a conventional procedure at our institution. Thereafter, from April 2012 to March 2016, soft coagulation using hemostatic forceps was performed as prophylactic hemostasis following an EP in five patients. For the latter procedure, the hemostatic forceps device (FD411‑QR, Olympus, Tokyo, Japan) was used in a closed position, with the coagulation wave set at 60 W (VIO 300D; ERBE, Tubingen, Germany). The primary outcome was the onset of PEPH, which was defined as a decrease in hemoglobin ≥2 g/dL after EP. Secondary endpoints were the success rate and the incidence of adverse events of soft coagulation using hemostatic forceps for emergency bleeding cases after EP. Results: The incidence of PEPH was 20% (1 of 5 cases) in the prophylactic procedure group, which was lower than that in the conventional procedures group (75%, 3 of 4 cases), though the difference was not statistically significant (P = 0.206, Fisher’s exact test). All cases of PEPH were successfully treated by soft coagulation using hemostatic forceps. Conclusion: Soft coagulation with hemostatic forceps may be suitable for use as a routine technique following EP to prevent PEPH.